Celgene Corporation to Present at the NewsMakers in the Biotech Industry Conference

SUMMIT, N.J.--(Business Wire)--
Celgene Corporation (NASDAQ: CELG) today announced its
presentation at the NewsMakers in the Biotech Industry Conference on
Thursday, September 4, 2008 at 2:00 p.m. EDT will be webcast live and
will be available in the investor relations section of the company's
Web site at www.celgene.com. David W. Gryska, Senior Vice President
and Chief Financial Officer, will provide an overview of the company.

Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in the
discovery, development and commercialization of novel therapies for
the treatment of cancer and inflammatory diseases through gene and
protein regulation. For more information, please visit the company's
website at www.celgene.com.

This release contains certain forward-looking statements which
involve known and unknown risks, delays, uncertainties and other
factors not under the Company's control, which may cause actual
results, performance or achievements of the Company to be materially
different from the results, performance or other expectations implied
by these forward-looking statements. These factors include results of
current or pending research and development activities, actions by the
FDA and other regulatory authorities, and those factors detailed in
the Company's filings with the Securities and Exchange Commission such
as 10K, 10Q and 8K reports.

Celgene Corporation
David W. Gryska, 908-673-9059
Senior Vice President and Chief Financial Officer
or
Brian P. Gill, 908-673-9530
Vice President, Corporate Communications

Copyright Business Wire 2008